Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page
- Check3 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small maintenance update to the page version. This does not alter trial data or visible content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that enrollment is closed. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment label was standardized, with the revision notice updated to v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a minor system update; the study details and user-facing content appear unchanged.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a new build or update. No study content or data appears to be changed by this update.SummaryDifference0.0%

- Check60 days agoChange DetectedA new revision tag (v3.5.3) replaces the previous tag (v3.5.2), signaling an update to the page's version.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.